Aquestive Therapeutics (AQST) Times Interest Earned: 2017-2025
Historic Times Interest Earned for Aquestive Therapeutics (AQST) over the last 9 years, with Sep 2025 value amounting to -$4.13.
- Aquestive Therapeutics' Times Interest Earned fell 38.52% to -$4.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.02, marking a year-over-year decrease of 152.37%. This contributed to the annual value of -$2.77 for FY2024, which is 16.09% down from last year.
- Per Aquestive Therapeutics' latest filing, its Times Interest Earned stood at -$4.13 for Q3 2025, which was down 1.05% from -$4.09 recorded in Q2 2025.
- Aquestive Therapeutics' 5-year Times Interest Earned high stood at $0.02 for Q2 2024, and its period low was -$7.81 during Q2 2022.
- For the 3-year period, Aquestive Therapeutics' Times Interest Earned averaged around -$3.28, with its median value being -$3.21 (2023).
- As far as peak fluctuations go, Aquestive Therapeutics' Times Interest Earned surged by 100.65% in 2024, and later crashed by 20,754.23% in 2025.
- Aquestive Therapeutics' Times Interest Earned (Quarterly) stood at -$6.69 in 2021, then rose by 2.96% to -$6.49 in 2022, then spiked by 73.50% to -$1.72 in 2023, then plummeted by 183.98% to -$4.89 in 2024, then plummeted by 38.52% to -$4.13 in 2025.
- Its Times Interest Earned stands at -$4.13 for Q3 2025, versus -$4.09 for Q2 2025 and -$6.96 for Q1 2025.